This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Granulomatosis With Polyangiitis, Microscopic Polyangiitis or Renal Limited Forms
and you are
over 18
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The aim of this study is to assess the efficacy of a rituximab regimen based on rate of ANCA and CD19 lymphocytes for maintenance treatment in systemic ANCA-associated vasculitis: prospective, multicenter, controlled, randomized comparative study of two rituximab regimens: one based on ANCA and CD19 lymphocytes versus systematic infusions.

Provided treatments

  • Drug: Rituximab (Arm B)
  • Drug: Rituximab (Arm A)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01731561. The sponsor of the trial is Assistance Publique - Hôpitaux de Paris and it is looking for 166 volunteers for the current phase.
Official trial title:
MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis II